Common Stock, par value $0.001 per share
- Symbol
- TNON
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01, 9.01 · 8-K
Tenon Medical, Inc.
TNONNASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. On September 9, 2026, Tenon Medical, Inc., a Delaware corporation (the “Company”), issued a press release (the “Press Release”) announcing that it repaid in full its outstanding original issue discount senior convertible promissory notes, which were issued with an aggregate principal balance of approximately $5.16 million, ahead of their September 11, 2026 maturity date.…
Company context
The Company was incorporated in the State of Delaware on June 19, 2012 and was headquartered in San Ramon, California until June 2021 when it relocated to Los Gatos, California. The Company is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. The Company currently offers two systems to treat a diseased sacroiliac joint (the “SI Joint”). The Company has developed The Catamaran™ SI Joint Fusion System (“The Catamaran System”) that offers a novel, less invasive approach to the SI Joint using a single, robust, titanium implant for treatment of the most common types of SI-Joint disorders that cause lower back pain. The Company received U.S. Food and Drug Administration (“FDA”) clearance in 2018 for The Catamaran System and is currently focused on the US market. The Company’s products are subject to ongoing FDA regulatory requirements, including requirements related to manufacturing, labeling, marketing, adverse event reporting and recordkeeping. Since the national launch of The Catamaran System in October 2022, the Company has been focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.
Current securities
Registered securities in this filing
TENON MEDICAL, INC. · 8-K · Filed 2026-09-09
Warrants
- Symbol
- TNONW
- Exchange
- NASDAQ
- Classification
- WARRANT
- Status
- Current
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On September 9, 2026,
Tenon Medical, Inc., a Delaware corporation (the “Company”), issued a press release (the “Press Release”) announcing
that it repaid in full its outstanding original issue discount senior convertible promissory notes, which were issued with an aggregate
principal balance of approximately $5.16 million, ahead of their September 11, 2026 maturity date.
A copy of the Press Release
is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information in this
Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “1934 Act”), nor shall it be deemed “incorporated by reference” into any
filing under the Securities Act of 1933, as amended, or the 1934 Act, except as may be expressly set forth by specific reference in such
filing.
Filed exhibits (1)
EX-99.1 2 ea030488401ex99-1.htm PRESS RELEASE OF TENON MEDICAL, INC., DATED SEPTEMBER 9, 2026 Exhibit 99.1 Tenon Medical Announces Early Repayment of its Convertible Notes ~ Company Takes Proactive Step to Strengthen Balance Sheet and Maintain Flexibility to Execute on Continued Business Momentum ~ Los Gatos, CA, September 9, 2026 - Tenon Medical, Inc. (NASDAQ: TNON) (“Tenon” or the “Company”), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced that it has repaid in full its outstanding original issue discount senior convertible promissory notes (the “Notes”), which were issued with an aggregate principal balance of approximately $5.16 million, ahead of their September 11, 2026 maturity date. The Notes were issued on March 11, 2026. The repayment represents a proactive step to strengthen Tenon’s balance sheet and eliminate the potential for the conversion of the Notes into shares of the Company’s common stock at a discount to market prices. “We believe repaying the Notes ahead of maturity is an important step forward for Tenon as we continue to build momentum across our business,” said Steven M. Foster,…
Open exhibit ↗